ZHAO Songji

J-GLOBAL         Last updated: Jun 8, 2019 at 10:01
 
Avatar
Name
ZHAO Songji
URL
http://www.fmu.ac.jp/
Affiliation
Fukushima Medical University
Section
Fukushima Global Medical Science Center Advanced Clinical Research Center
Job title
Professor
Degree
PhD(Hokkaido University), Master(Baiqiuen Medical College), MD(Yanbian Medical College)

Research Areas

 
 

Education

 
Apr 1999
 - 
Mar 2003
PhD in Medicine, Graduate School of Medicine, Hokkaido University
 
Sep 1987
 - 
Jul 1990
MSc, Baiqiuen Medical College, Jilin University
 

Published Papers

 
Zhao S, Yu W, Ukon N, Tan C, Nishijima KI, Shimizu Y, Higashikawa K, Shiga T, Yamashita H, Tamaki N, Kuge Y
EJNMMI research   9(1) 51   Jun 2019   [Refereed]
Shimizu Y, Zhao S, Yasui H, Nishijima KI, Matsumoto H, Shiga T, Tamaki N, Ogawa M, Kuge Y
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging   21(1) 122-129   Feb 2019   [Refereed]
Nakata N, Kiriu M, Okumura Y, Zhao S, Nishijima KI, Shiga T, Tamaki N, Kuge Y, Matsumoto H
Nuclear medicine and biology   70 39-45   Feb 2019   [Refereed]
Tan C, Zhao S, Higashikawa K, Wang Z, Kawabori M, Abumiya T, Nakayama N, Kazumata K, Ukon N, Yasui H, Tamaki N, Kuge Y, Shichinohe H, Houkin K
EJNMMI research   8(1) 35   May 2018   [Refereed]
Yamasaki K, Yamashita A, Zhao Y, Shimizu Y, Nishii R, Kawai K, Tamaki N, Zhao S, Asada Y, Kuge Y
Nuclear medicine and biology   56 21-25   Jan 2018   [Refereed]
Oshima N, Akizawa H, Kitaura H, Kawashima H, Zhao S, Zhao Y, Nishijima KI, Kitamura Y, Arano Y, Kuge Y, Ohkura K
Nuclear medicine and biology   54 18-26   Nov 2017   [Refereed]
Masaki Y, Shimizu Y, Yoshioka T, Nishijima KI, Zhao S, Higashino K, Numata Y, Tamaki N, Kuge Y
Annals of nuclear medicine   31(8) 596-604   Oct 2017   [Refereed]
Maejima Y, Horita S, Kobayashi D, Aoki M, O'hashi R, Imai R, Sakamoto K, Mori M, Takasu K, Ogawa K, Takenoshita S, Zhao S, Hazama A, Shimomura K
Peptides   95 10-15   Sep 2017   [Refereed]
Shimizu Y, Hanzawa H, Zhao Y, Fukura S, Nishijima KI, Sakamoto T, Zhao S, Tamaki N, Ogawa M, Kuge Y
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging   19(4) 531-539   Aug 2017   [Refereed]
Yu W, Zhao S, Zhao Y, Fatema CN, Murakami M, Nishijima KI, Kitagawa Y, Tamaki N, Kuge Y
Oncology letters   14(2) 2341-2346   Aug 2017   [Refereed]
Zhao S, Fatema CN, Zhao J, Nan G
Journal of nuclear medicine : official publication, Society of Nuclear Medicine   57(9) 1333   Sep 2016   [Refereed]
Oshima N, Akizawa H, Kawashima H, Zhao S, Zhao Y, Nishijima KI, Kitamura Y, Arano Y, Kuge Y, Ohkura K
Nuclear medicine and biology   48 16-25   May 2017   [Refereed]
Hanzawa H, Sakamoto T, Kaneko A, Manri N, Zhao Y, Zhao S, Tamaki N, Kuge Y
Journal of proteome research   14(10) 4257-4269   Oct 2015   [Refereed]
Ukon N, Zhao S, Yu W, Shimizu Y, Nishijima KI, Kubo N, Kitagawa Y, Tamaki N, Higashikawa K, Yasui H, Kuge Y
EJNMMI research   6(1) 90   Dec 2016   [Refereed]
Masaki Y, Shimizu Y, Yoshioka T, Tanaka Y, Nishijima KI, Zhao S, Higashino K, Sakamoto S, Numata Y, Yamaguchi Y, Tamaki N, Kuge Y
Scientific reports   5 16802   Nov 2015   [Refereed]
Masaki Y, Shimizu Y, Yoshioka T, Feng F, Zhao S, Higashino K, Numata Y, Kuge Y
PloS one   11(8) e0161639   2016   [Refereed]
Sugimoto M, Wakabayashi M, Shimizu Y, Yoshioka T, Higashino K, Numata Y, Okuda T, Zhao S, Sakai S, Igarashi Y, Kuge Y
PloS one   11(3) e0152191   May 2016   [Refereed]
Kobashi N, Matsumoto H, Zhao S, Meike S, Okumura Y, Abe T, Akizawa H, Ohkura K, Ken-Ichi N, Tamaki N, Kuge Y
Journal of nuclear medicine   57(8) 1276-1281   Aug 2016   [Refereed]
Sugimoto M, Shimizu Y, Zhao S, Ukon N, Nishijima K, Wakabayashi M, Yoshioka T, Higashino K, Numata Y, Okuda T, Tamaki N, Hanamatsu H, Igarashi Y, Kuge Y
Biochimica et biophysica acta   1861(8 Pt A) 688-702   Aug 2016   [Refereed]
INVITED PERSPECTIVE FOR: Advanced Molecular Imaging for Exploring Classical Conditioning and Extinction
Zhao S, Fatema CN, Zhao JM, and Nan GX
J Nucl Med   57(9) 1333   Sep 2016   [Refereed][Invited]
Immunoglobulin-G (IgG)-based imaging probe accumulates in M1 macrophage-infiltrated atherosclerotic plaques independent of IgG target molecule expression
Shimizu Y, Hanzawa H, Zhao Y, Fukura S, Nishijima K, Sakamoto T, Zhao S, Tamaki N, Ogawa M, Kuge Y
Mol Imaging Biol      Dec 2016   [Refereed]
Zhao S, Li H, Nishijima K, Zhao Y, Akizawa H, Shimizu Y, Ohkura K, Tamaki N, Kuge Y.
Annals of nuclear medicine.   29(7) 582-587   Aug 2015   [Refereed]
Optimization of Helical Acquisition Parameters to Preserve Uniformity of Mouse Whole Body using Multipinhole Collimator in Single-Photon Emission Computed Tomography
Ukon N, Kubo N, Ishikawa M, Zhao S, Tamaki N, Kuge Y
Results in Physics      2017   [Refereed]
Yamasaki K, Zhao S, Nishimura M, Zhao Y, Yu W, Shimizu Y, Nishijima K, Tamaki N, Takeda H, Kuge Y
EJNMMI Res   14 1-11   2015   [Refereed]
Redesign of negatively charged 111In-DTPA-octreotide derivative to reduce renal radioactivity. Nucl Med and Biol
Oshima N, Akizawa H, Kawashima H, Zhao S, Zhao Y, Nishijima K, Kitamura Y, Arano Y, Kuge Y, Ohkura K
Nucl Med Biol   48(1) 16-25   Jan 2017   [Refereed]
Zhao Y, Fukao K, Zhao S, Watanabe A, Hamada T, Yamasaki K, Shimizu Y, Kubo N, Ukon N, Nakano T, Tamaki N, Kuge Y
Molecular imaging   14 1-8   2015   [Refereed]
Changes in tumor oxygen states after sorafenib therapy evaluated by 18F-fluoromisonidazole hypoxia imaging in a renal cell cancer xenograft
Yu W, Zhao S, Zhao Y, Fatema CN, Murakami M, Nishijima K, Kitagawa Y, Tamaki N, Kuge Y
Oncology Letters   in press    Jun 2017   [Refereed]
Yamaguchi A, Hanaoka H, Fujisawa Y, Zhao S,・Suzue K,・Morita A, Tominaga H, Higuchi T, Hisaeda H, Kuge Y, Tsushima Y, Iida Y.
EJNMMI Research.   5 29   Apr 2015   [Refereed]
Yimin, Kohanawa M, Zhao S, Li M, Kuge Y, Tamaki N, Watanabe M
Journal of Interferon & Cytokine Research.   35(3) 222-231   Mar 2015   [Refereed]
Fatema CN, Zhao S, Zhao Y, Yu W, Nishijima K, Yasuda K, Kitagawa Y, Tamaki N, Kuge Y
BMC cancer   14 692   Sep 2014   [Refereed]
Oshima N, Akizawa H, Zhao S, Zhao Y, Nishijima K, Kitamura Y, Arano Y, Kuge Y, Ohkura K
Bioorganic & Medicinal Chemistry   22 1377-1382   Feb 2014   [Refereed]
Yamashita A, Zhao Y, Matsuura Y, Yamasaki K, Moriguchi-Goto S, Sugita C, Iwakiri T, Okuyama N, Koshimoto C, Kawai K, Tamaki N, Zhao S, Kuge Y, Asada Y
PLoS One   9 e86426   Jan 2014   [Refereed]
Zhao Y, Watanabe A, Zhao S, Kobayashi T, Fukao K, Tanaka Y, Nakano T, Yoshida T, Takemoto H, Tamaki N, Kuge Y
PLoS One   9 e89338   Feb 2014   [Refereed]
Zhao S, Kuge Y, Zhao Y, Takeuchi S, Hirata K, Takei T, Shiga T, Dosaka-Akita H, Tamaki N
BMC cancer   13 525   Nov 2013   [Refereed]
Murakami M, Zhao S, Zhao Y, Yu W, Fatema CN, Nishijima KI, Yamasaki M, Takiguchi M, Tamaki N, Kuge Y
Oncology Letters   6 667-672   Sep 2013   [Refereed]
Yimin, Kohanawa M, Zhao S, Ozaki M, Haga S, Nan G, Kuge Y, Tamaki N
PLoS One   8(9) e74287   Sep 2013   [Refereed]
Zhao Y, Zhao S, Kuge Y, Tamaki N
Journal of Nuclear Medicine   54(8) 1384-1388   Aug 2013   [Refereed]
Nagane M, Yasui H, Yamamori T, Zhao S, Kuge Y, Tamaki N, Kameya H, Nakamura H, Fujii H, Inanami O
Biochemical and Biophysical Research Communications   437(3) 420-425   Aug 2013   [Refereed]
Attenuation of apoptosis by telmisartan in atherosclerotic plaques of apolipoprotein E-/- mice: evaluation using technetium 99m-annexin A5.
Zhao Y, Zhao S, Kuge Y, Strauss HW, Blankenberg FG, Tamaki N
Molecular Imaging   12(5) 300-309   Jul 2013   [Refereed]
Saito H, Magota K, Zhao S, Kubo N, Kuge Y, Shichinohe H, Houkin K, Tamaki N, Kuroda S
Stroke   44(10) 2869-2874   Oct 2013   [Refereed]
Fatema CN, Zhao S, Zhao Y, Murakami M, Yu W, Nishijima KI, Tamaki N, Kitagawa Y, Kuge Y
Annals of Nuclear Medicine   27(4) 355-362   May 2013   [Refereed]
Hatano T, Zhao S, Zhao Y, Nishijima K, Kuno N, Hanzawa H, Sakamoto T, Tamaki N, Kuge Y
International Journal of Oncology   42(3) 823-830   Mar 2013   [Refereed]
Miyamoto M, Kuroda S, Zhao S, Magota K, Shichinohe H, Houkin K, Kuge Y, Tamaki N
Journal of Nuclear Medicine   54(1) 145-150   Jan 2013   [Refereed]
Arterial (18)F-fluorodeoxyglucose uptake reflects balloon catheter-induced thrombus formation and tissue factor expression via nuclear factor-κB in rabbit atherosclerotic lesions.
Yamashita A, Zhao Y, Zhao S, Matsuura Y, Sugita C, Iwakiri T, Okuyama N, Ohe K, Koshimoto C, Kawai K, Tamaki N, Kuge Y, Asada Y
Circulation Journal   77(10) 2626-2635   2013   [Refereed]
Murakami M, Zhao S, Zhao Y, Chowdhury NF, Yu W, Nishijima K, Takiguchi M, Tamaki N, Kuge Y
International Journal of Oncology   41(5) 1593-1600   Nov 2012   [Refereed]
Watanabe A, Nishijima K, Zhao S, Zhao Y, Tanaka Y, Takemoto H, Strauss HW, Blankenberg FG, Tamaki N, Kuge Y
Journal of Nuclear Medicine   53(10) 1585-1591   Oct 2012   [Refereed]
Yimin, Furumaki H, Matsuoka S, Sakurai T, Kohanawa M, Zhao S, Kuge Y, Tamaki N, Chiba H
Laboratory Investigation   92(2) 265-281   Feb 2012   [Refereed]
Watanabe A, Nishijima K, Zhao S, Tanaka Y, Itoh T, Takemoto H, Tamaki N, Kuge Y
Annals of Nuclear Medicine   26(2) 184-191   Feb 2012   [Refereed]
Ferrous ferric chloride downregulates the inflammatory response to Rhodococcus aurantiacus infection in mice.
Yimin, Tao H, Kohanawa M, Zhao S, Kuge Y, Tamaki N
Biological & Pharmaceutical Bulletin   35(12) 2214-2223   2012   [Refereed]
Li H, Zhao S, Jin Y, Nishijima K, Akizawa H, Ohkura K, Tamaki N, Kuge Y
Nuclear Medicine Communications   32(12) 1211-1215   Dec 2011   [Refereed]
Zhao S, Kuge Y, Yi M, Zhao Y, Hatano T, Magota K, Nishijima K, Kohanawa M, Tamaki N
European Journal of Nuclear Medicine and Molecular Imaging   38(10) 1876-1886   Oct 2011
Takeuchi S, Zhao S, Kuge Y, Zhao Y, Nishijima K, Hatano T, Shimizu Y, Kinoshita I, Tamaki N, Dosaka-Akita H
Oncology Reports   26(3) 725-730   Sep 2011   [Refereed]
Zhao Y, Zhao S, Kuge Y, Strauss WH, Blankenberg FG, Tamaki N
Molecular Imaging and Biology   13(4) 712-720   Aug 2011   [Refereed]
Magota K, Kubo N, Kuge Y, Nishijima K, Zhao S, Tamaki N
European Journal of Nuclear Medicine and Molecular Imaging   38(4) 742-752   Apr 2011   [Refereed]
Akizawa H, Zhao S, Takahashi M, Nishijima K, Kuge Y, Tamaki N, Seki K, Ohkura K
Nuclear Medicine and Biology   37(4) 427-432   May 2010
Sano K, Temma T, Kuge Y, Kudo T, Kamihashi J, Zhao S, Saji H
Biological & Pharmaceutical Bulletin   33(9) 1589-1595   2010   [Refereed]
Molecular imaging of apoptosis with radio-labeled Annexin A5 focused on the evaluation of tumor response to chemotherapy.
Kuge Y, Zhao S, Takei T, Tamaki N
Anticancer Agents in Medicinal Chemistry   9(9) 1003-1011   Nov 2009   [Refereed]
Ueno Y, Morimoto Y, Tsuchiya K, Yanagita N, Kojima S, Ishitsu T, Kitaguchi H, Kubo N, Zhao S, Tamaki N, Amemiya K.
IEEE Trans Nucl Sci   56(1,Pt.1) 24-28   2009   [Refereed]
Yimin, Kohanawa M, Ozaki M, Haga S, Fujikawa K, Zhao S, Kuge Y, Tamaki N
Microbes and Infection   10(14-15) 1450-1458   Nov 2008   [Refereed]
Zhao Y, Kuge Y, Zhao S, Strauss HW, Blankenberg FG, Tamaki N
Journal of Nuclear Medicine   49(10) 1707-1714   Oct 2008   [Refereed]
Zhao S, Kuge Y, Kohanawa M, Takahashi T, Zhao Y, Yi M, Kanegae K, Seki K, Tamaki N
Journal of Nuclear Medicine   49(1) 135-141   Jan 2008   [Refereed]
Synthesis of a radioiodinated thymidine phosphorylase inhibitor and its preliminary evaluation as a potential SPECT tracer for angiogenic enzyme expression.
Takahashi M, Seki K, Nishijima K, Zhao S, Kuge Y, Tamaki N, Ohkura K.
J Label Compd Radiopharm   51(11) 384-387   Nov 2008   [Refereed]
Zhao S, Kuge Y, Kohanawa M, Takahashi T, Kawashima H, Temma T, Takei T, Zhao Y, Seki K, Tamaki N
European Journal of Nuclear Medicine and Molecular Imaging   34(12) 2096-2105   Dec 2007   [Refereed]
Zhao Y, Kuge Y, Zhao S, Morita K, Inubushi M, Strauss HW, Blankenberg FG, Tamaki N
European Journal of Nuclear Medicine and Molecular Imaging   34(11) 1747-1755   Nov 2007   [Refereed]
All-trans retinoic acid enhances murine dendritic cell migration to draining lymph nodes via the balance of matrix metalloproteinases and their inhibitors.
Darmanin S, Chen J, Zhao S, Cui H, Shirkoohi R, Kubo N, Kuge Y, Tamaki N, Nakagawa K, Hamada J, Moriuchi T, Kobayashi M
Journal of Immunology   179(7) 4616-4625   Oct 2007   [Refereed]
Kanegae K, Nakano I, Kimura K, Kaji H, Kuge Y, Shiga T, Zhao S, Okamoto S, Tamaki N
Annals of Nuclear Medicine   21(6) 331-337   Aug 2007   [Refereed]
Evaluating performance of a pixel array semiconductor SPECT system for small animal imaging.
Kubo N, Zhao S, Fujiki Y, Kinda A, Motomura N, Katoh C, Shiga T, Kawashima H, Kuge Y, Tamaki N
Annals of Nuclear Medicine   19(7) 633-639   Oct 2005
Enhanced apoptotic reaction correlates with suppressed tumor glucose utilization after cytotoxic chemotherapy: use of 99mTc-Annexin V, 18F-FDG, and histologic evaluation.
Takei T, Kuge Y, Zhao S, Sato M, Strauss HW, Blankenberg FG, Tait JF, Tamaki N
Journal of Nuclear Medicine   46(5) 794-799   2005   [Refereed]
Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor.
Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M, Takei T, Tamaki N
Journal of Nuclear Medicine   46(4) 675-682   Apr 2005   [Refereed]
Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
Nakada K, Ishibashi T, Takei T, Hirata K, Shinohara K, Katoh S, Zhao S, Tamaki N, Noguchi Y, Noguchi S.
J Nucl Med   46(2) 261-266   Feb 2005   [Refereed]
Time course of apoptotic tumor response after a single dose of chemotherapy: comparison with 99mTc-annexin V uptake and histologic findings in an experimental model.
Takei T, Kuge Y, Zhao S, Sato M, Strauss HW, Blankenberg FG, Tait JF, Tamaki N
Journal of Nuclear Medicine   45(12) 2083-2087   Dec 2004   [Refereed]
Gastrointestinal uptake of FDG after N-butylscopolamine or omeprazole treatment in the rat.
Yamamoto F, Nakada K, Zhao S, Satoh M, Asaka M, Tamaki N
Annals of Nuclear Medicine   18(7) 637-640   Oct 2004
Feasibility of 99mTc-annexin V for repetitive detection of apoptotic tumor response to chemotherapy: an experimental study using a rat tumor model.
Kuge Y, Sato M, Zhao S, Takei T, Nakada K, Seki KI, Strauss HW, Blankenberg FG, Tait JF, Tamaki N
Journal of Nuclear Medicine   45(2) 309-312   Feb 2004   [Refereed]
Effect of steroids on [18F]fluorodeoxyglucose uptake in an experimental tumor model
Zhao S, Kuge Y, Nakada K, Mochizuki T, Takei T, Okada F, Tamaki N.
Nucl Med Commun   25(7) 727-730   Jul 2004   [Refereed]
Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism.
Chen J, Zhao S, Nakada K, Kuge Y, Tamaki N, Okada F, Wang J, Shindo M, Higashino F, Takeda K, Asaka M, Katoh H, Sugiyama T, Hosokawa M, Kobayashi M
The American Journal of Pathology   162(4) 1283-1291   Apr 2003   [Refereed]
Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V.
Mochizuki T, Kuge Y, Zhao S, Tsukamoto E, Hosokawa M, Strauss HW, Blankenberg FG, Tait JF, Tamaki N
Journal of Nuclear Medicine   44(1) 92-97   Jan 2003   [Refereed]
Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumours: effects of insulin and glucose loading. Nucl Med Commun
Zhao S, Kuge Y, Tsukamoto E, Mochizuki T, Kato T, Hikosaka K, Nakada K, Hosokawa M, Kohanawa M, Tamaki N.
Nucl Med Commun   23(6) 545-550   Jun 2002   [Refereed]
FDG uptake and glucose transporter subtype expression in experimental tumor and inflammation models.
Mochizuki T, Tsukamoto E, Kuge Y, Kanegae K, Zhao S, Hikosaka K, Hosokawa M, Kohanawa M, Tamaki N.
J Nucl Med   42(10) 1551-1555   Oct 2001   [Refereed]
Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions.
Zhao S, Kuge Y, Tsukamoto E, Mochizuki T, Kato T, Hikosaka K, Hosokawa M, Kohanawa M, Tamaki N.
Eur J Nucl Med   28(6) 730-735   Jun 2001   [Refereed]
Avidin chase can raduce myelotoxicity associated with radioimmunotherapy of experimental liver micrometastases in mice.
Sato N, Saga T, Sakahara H, Nakamoto Y, Zhao S, Kuroki M, Endo K, Konishi J.
Jpn J Cancer Res   91(6) 622-628   Jun 2000   [Refereed]
Radioimmunotherapy of human glioma xenografts in nude mice by indium-111 labelled internalising monoclonal antibody.
Saga T, Sakahar H, Nakamoto Y, Sato N, Zhao S, Aoki T, Miyatake S, Namba Y, Konishi J.
Eur J Cancer   35(8) 1281-1285   Aug 1999   [Refereed]
Radioimmunotherapy for liver micometastases in mice: pharmacokinetics, dose estimation, and long-term effect.
Saga T, Sakahara H, Nakamoto Y, Sato N, Zhao S, Iido Y, Kuroki M, Endo K, Konishi J.
Jpn J Cancer Res   90(3) 342-348   Mar 1999   [Refereed]
Nakamoto Y, Sakahar H, Saga T, Sato N, Zhao S, Arano Y, Fujioka Y, Saji H, Konishi J.
Br J Cancer   79(11/12) 1794-1799   Apr 1999   [Refereed]
The relationship of glycosylation and isoelectric point with tumor accumulation of avidin.
Yao Z, Zhang M, Sakahara H, Nakamoto Y, Higasi T, Zhao S, Sato N, Arano Y, Konishi J.
J Nucl Med   40(3) 479-483   Mar 1999   [Refereed]
A radioiodinated biocytin derivative for in-vivo applications.
Nakamoto Y, Sakahara H, Saga T, Yao Z, Zhang M, Sato N, Zhao S, Arano Y, Ono M, Saji H, Konishi J.
Nucl Med Commun   19(10) 963-969   Oct 1998   [Refereed]
Imaging of intraperitoneal tumors with technetium-99m GSA.
Yao Z, Zhang M, Sakahara H, Saga T, Nakamoto Y, Sato N, Zhao S, Arano Y, Konishi J.
Ann Nucl Med   12(2) 115-118   Apr 1998   [Refereed]
Zhang M, Yao Z, Sakahara H, Saga T, Nakamoto Y, Sato N, Zhao S, Nakada H, Yamashina I, Konishi J.
Nucl Med Biol   25(2) 101-105   Feb 1998   [Refereed]
Nakamoto Y, Saga T, Sakahara H, Yao Z, Zhang M, Sato N, Zhao S, Nakada H, Yamashina I, Konishi J:
Nucl Med Biol   25(2) 95-99   Feb 1998
Detection of altered adhesion molecule expression in experimental tumors by a radiolabeled monoclonal antibody.
Saga T, Sakahara H, Yao Z, Nakamoto Y, Sato N, Hattori N, Zhang M, Zhao S, Aoki T, Miyatate S, Namba Y, Konishi J
Jpn J Cancer Res   88(12) 1171-1180   Oct 1997   [Refereed]
アスパラギン酸で負電荷を付与した111In‐DTPA‐D‐Phe1‐オクトレオチド誘導体の受容体親和性および体内動態の評価
大島伸宏, 秋澤宏行, 趙松吉, 趙芫, 西嶋剣一, 北村陽二, 荒野泰, 久下裕司, 久下裕司, 大倉一枝
日本薬学会年会要旨集   132nd(4) 146   2012
放射性標識核酸誘導体による腫瘍の核医学診断と内用療法
秋澤宏行, 趙松吉, 高橋正幸, 西嶋剣一, 松本博樹, 関興一, 玉木長良, 久下裕司, 大倉一枝
日本薬学会年会要旨集   132nd(1) 116   2012
新規腫瘍内低酸素イメージング剤18F‐HIC101の有用性の評価
中田徳仁, 奥村侑紀, 永田絵里子, 桐生真登, 林明希男, 西嶋剣一, 趙松吉, 玉木長良, 久下裕司, 久下裕司, 松本博樹
日本薬学会年会要旨集   132nd(4) 104   2012
チミジンホスホリラーゼイメージング剤[123I]5‐iodo‐6‐[(2‐iminoimidazokidinyl)methyl]uracilの開発:タンパク結合測定と画像化の検討
西嶋剣一, 越田早織, 趙松吉, 秋澤宏行, 大倉一枝, 松本博樹, 志賀哲, 玉木長良, 久下裕司, 久下裕司
日本薬学会年会要旨集   132nd(4) 106   2012
骨髄間質細胞移植は脳梗塞周囲の神経受容体機能を改善させる―123I‐iomazenil SPECTによる検討
齋藤久泰, 黒田敏, 宮本倫行, 山内朋裕, 七戸秀夫, 趙松吉, 孫田惠一, 久保直樹, 久下裕司, 玉木長良, 寶金清博
脳循環代謝   24(1) 216   2012
小動物用PETを用いた[11C]Flumazenilのコンパートメントモデル解析におけるMaximum a posteriori(MAP)再構成の評価
孫田惠一, 久保直樹, 趙松吉, 久下裕司, 玉木長良, 加藤千恵次
北海道放射線技術雑誌   71 127   2011
核医学検査の新しい展開~治療戦略への応用 治療戦略に役立つ放射性薬剤の開発
久下裕司, 久下裕司, 西嶋剣一, 趙松吉
映像情報Medical   43(11) 842-849,830   2011
小動物用PETを用いた11C‐FlumazenilのBinding potential解析におけるMaximum a posteriori再構成の評価
孫田惠一, 久保直樹, 趙松吉, 久下裕司, 平田健司, 服部直也, 志賀哲, 加藤千恵次, 玉木長良
核医学   48(3) 329   2011
ヒト癌移植マウスにおける抗EGFR抗体(Cetuximab)による分子標的療法:18F‐FMISOを用いた早期治療効果評価
趙松吉, 久下裕司, 趙芫, 竹内啓, 村上正紘, 李花, 西嶋剣一, 竹井俊樹, 秋田弘俊, 玉木長良
核医学   48(3) 335   2011
心筋交感神経終末機能評価薬剤11C‐hydroxyephedrineの安全性評価
西嶋剣一, 吉永恵一郎, 趙松吉, 趙芫, 真鍋治, 加藤千恵次, 阿保憲史, 玉木長良, 久下裕司, 久下裕司
核医学   48(3) 318   2011
ApoE‐/‐マウス動脈硬化に対するテルミサルタンの治療効果:99mTc‐annexin A5による評価
趙芫, 趙松吉, 久下裕司, 玉木長良
核医学   48(3) 292   2011

Books etc

 
In: Molecular Imaging for Integrated Medical Therapy and Drug Development (Kuge Y, Shiga T, Tamaki N eds.)
Kuge Y, Shiga T, Tamaki N eds. (Part:Joint Work, Semiconductor detector-based scanner for nuclear medicine)
Springer (Springer Science+Business Media), Heidelberger   2016   
In: Prespectives on Nuclear Medicine for Molecular Diagnosis and Integrated Therapy (Kuge Y, Shiga T, Tamaki N eds.)
Kuge Y, Shiga T, Tamaki N eds. (Part:Joint Work, Preclinical evaluation of a thymidine phosphorylase imaging probe, [123I]IIMU, for the translational research)
Springer (Springer Science+Business Media), Heidelberger   2016   
In: Prespectives on Nuclear Medicine for Molecular Diagnosis and Integrated Therapy (Kuge Y, Shiga T, Tamaki N eds.)
Kuge Y, Shiga T, Tamaki N eds. (Part:Joint Work, Discovery and Evaluation of Biomarkers for Atherosclerosis Differential Proteomic of Plasma and Tissues)
Springer (Springer Science+Business Media), Heidelberger   2016   
In: Prespectives on Nuclear Medicine for Molecular Diagnosis and Integrated Therapy (Kuge Y, Shiga T, Tamaki N eds.)
Kuge Y, Shiga T, Tamaki N eds. (Part:Joint Work, Radioimmunodetection of Atherosclerotic Lesions Focusing on the Accumulation Mechanism of Immunoglobulin G.)
Springer (Springer Science+Business Media), Heidelberger   2016   
Molecular Imaging for the Assessment of Tumor Malignancy and Response to Therapy. In: Molecular Imaging for Integrated Medical Therapy and Drug Development (Tamaki N, Kuge Y eds.).
Springer (Springer Science+Business Media), Heidelberger   2010   
Molecular Imaging for the Assessment of Tumor Malignancy and Response to Therapy. In:Molecular Imaging for Integrated Medical Therapy and Drug Development (Tamaki N, Kuge Y eds.).
Springer (Springer Science+Business Media), Heidelberger   2010   
Molecular Imaging for the Assessment of Tumor Malignancy and Response to Therapy. In:Molecular Imaging for Integrated Medical Therapy and Drug Development (Tamaki N, Kuge Y eds.).
Springer (Springer Science+Business Media), Heidelberger   2010   
Molecular Imaging for the Assessment of Tumor Malignancy and Response to Therapy. In: Molecular Imaging for Integrated Medical Therapy and Drug Development (Tamaki N, Kuge Y eds.).
Springer (Springer Science+Business Media), Heidelberger   2010   
In: PET and Molecular Imaging: State of the art and future perspectives.
International Congress Series 1264: Radiology (Tamaki N, Kuge Y eds)   2004   
In: PET and Molecular Imaging: State of the art and future perspectives (Tamaki N, Kuge Y eds.)
International Congress Series 1264: Radiology (Tamaki N, Kuge Y eds)   2004   

Conference Activities & Talks

 
An effort to diagnostic and therapeutic nuclear medicine at Fukushima Medical University using two medical cyclotrons.
Washiyama K, Aoki M, Joho T, Ukon N, Nishijima K, Takahashi K, Zhao S, Oriuchi N
International Symposium on Traends in Radiopharmaceuticals (ISTR 2019)   28 Oct 2019   
Delta-like 1 homolog (DLK1) expression in non-small-cell lung cancer and the development of radioimmunotherapy targeting DLK1
Takagi H, Zhao S, Muto S, Mine H, Watanabe M, Ozaki Y, Okabe N, Hasegawa T, Shio Y, Aoki M, Tan C, Shimoyama S, Nakamura K, Inano A, Suzuki H
World Coference on Lung Cancer (WCLC 2019)   7 Sep 2019   
Evaluation of the potential of organ glucose metabolism by 18F-FDG accumulation with insulin loading in older mice compared with younger normal mice
Tan C, Zhao S*, Ukon N, Shimoyama S, Aoki M, Horita S, Imai R, Maejima Y, Takenoshita S, Shimomura K
The 66th Society of Nuclear Medicine Annual Meeting (SNMMI 2019)   23 Jun 2019   
Possibility of 123I-meta-iodobenzylguanidine (123I-MIBG) as companion diagnostic drug for therapeutic alpha-emitting meta-211At-astato-benzylguanidine (211At-MABG)
Yoshinaga K, Zhao S, Washino K, Aoki M, Nishijima K, Shimoyama S, Ukon N, Tan C, Washiyama K, Takahashi K, Ito H, Higashi T
The 66th Society of Nuclear Medicine Annual Meeting (SNMMI 2019)   22 Jun 2019   
Synthesis of [211At]MABG Using Remote-controlled Synthesizer and Quality Evaluation
Aoki M, Minegishi K, Nishijima K, Suzuki H, Sasaki S, Washiyama K, Zhao S, Nagatsu K, Zhang M, Takahashi K
The ISRS 2019   26 May 2019   
Biodistribution and dosimetry of Free and meta-[211At]astatobenzylguanidine (MABG) in normal mice
Ukon N, Zhao S, Washiyama K, Oriuchi N, Aoki M, Tan C, Nishijima K, Kubo H, Takahashi K, Ito H
The 11th International Symposium on TargetedAlpha-Therapy (TAT11)   1 Apr 2019   
Manufacture of [211At]MABG Using Remote-controllable Synthesizer and Quality Evaluation
ZHAO Songji
20 Mar 2019   
Evaluation of the distribution of At-211 solution dispersion in the small an imal cage
ZHAO Songji
15 Nov 2018   
Is it possible to detect the contamination of At-211 using survey meter ?
ZHAO Songji
15 Nov 2018   
Manufacture and Quality Evaluation Using Synthesizer of [211At]MABG
ZHAO Songji
15 Nov 2018   
Dosimetry of free 211At and meta-[211At]astatobenzylguanidine (MABG) in normal mice
ZHAO Songji
15 Nov 2018   
正常マウスにおけるフリー211Atおよびmeta-[211At]astatobenzylguanidine (MABG)の体内動態
Zhao S, Aoki M, Washiyama K, Ukon N, Tan C, Shimoyama S, Kubo H, Oriuchi N, Takahashi K, Ito H, Takenoshita S
15 Nov 2018   
Investigation of the influence of intratumoral glutathione status on the distribution of a hypoxic probe [18F]FMISO
Yasui H, Higashikawa K, Shimizu Y, Shibata Y, Zhao S, Matsumoto H, Shiga T, Tamaki N, Kuge Y
WFNMB 2018   4 Apr 2018   
Preclinical evaluation of [18F]DiFA, a novel PET probe for tumor hypoxia, in comparison with [18F]MISO
Yasui H, Zhao S, Higashikawa K, Ukon N, Shimizu Y, Matsumoto H, Tamaki N, Kuge Y
The 64rd Society of Nuclear Medicine Annual Meeting (SNMMI 2017)   10 Jun 2017   
Accumulation mechanism of novel PET imaging probe “[18F]DiFA” in hypoxic cells revealed by imaging mass spectrometry
Shimizu Y, Zhao S, Kishi R, Yasui H, Nishijima K, Matsumoto H, Tamaki N, Ogawa M, Kuge Y
The 64rd Society of Nuclear Medicine Annual Meeting (SNMMI 2017)   10 Jun 2017   
Effect of eribulin on remodeling of tumor vasculature confirmed by FMISO PET imaging-Small-animal PET study in human breast cancer cell xenograft
Zhao S, Yu W, Ukon N, Nishijima K, Shimizu Y, Higashikawa K, Yamashita H, Tamaki N, Kuge Y
The 64rd Society of Nuclear Medicine Annual Meeting (SNMMI 2017)   10 Jun 2017   
The Production of 211At at Fukushima Medical University
Aoki M, Tominaga H Kato J, Oda T, Zhao S, Hiasa T, Oriuchi N, Takenoshita S
The 10th International Symposium on Targeted Alpha Therapy (TAT-10) in Kanazawa   30 May 2017   
Production of At-211 by In-house Cyclotron and Characterization at Fukushima Medical University
Oriuchi N, Tominaga H, Zhao S, Aoki M, Takenoshita S, Oda T, Zhang M, Nagatsu K, Higashi T, Ishioka N
The 76th Annual Meeting of the Japan Radiological Society   13 Apr 2017   
Inflammatory Changes in Brain and Lymphoid Organs after Ischemic Stroke: PET Imaging for Cell Therapy
Tan C, Wang Z, Shichinohe H, Zhao S, Kuge Y, Kawabori M, Abumiya T, Nakayama N, Kazumata K, Houkin K
the International Stroke Conference 201T   21 Feb 2017   
Preclinical Translational Researches of Novel PET and SPECT Tracers: 18F-FDiFA and 123I-IIMU for Hypoxia and Thymidine Phosphorylase Imaging [Invited]
Zhao S, NishijimaK, Matsumoto H, Akizawa H, Ohkura K, Tamaki N, Kuge Y
The Asia Oceania Federation of Nuclear Medicine and Biology (AOFNMB) 2015   31 Oct 2015   The Asia Oceania Federation of Nuclear Medicine and Biology (AOFNMB)
Effects of eribulin on remodeling of tumor vascular evaluated with FMISO hypoxia imaging in a human breast cancer cell xenograft
Zhao S, Yu W, Ukon N), Nishijima K, Yamashita H, Tamaki N, Kuge Y
The 63rd Society of Nuclear Medicine Annual Meeting   11 Jun 2016   
Metabolic Aspects of [14C]Acetete in Rabbit Atherosclerotic Arteries at Different Feeding Conditions: In Vitro Evaluation for Atherosclerosis Imaging with [11C]Acetate
Yamasaki K, Yamashita A, Zhao Y, Shimizu Y, Kawai K, Tamaki N, Zhao S, Asada Y, Kuge Y
The 63rdSociety of Nuclear Medicine Annual Meeting (SNMMI 2016)   11 Jun 2016   Society of Nuclear Medicine Annual Meeting
Does FMISO-PET really visualize only hypoxic states?; accumulation mechanism assessment of FMISO in hypoxic cells in combination with mass spectrometry
Shimizu Y, Masaki Y, Yoshioka T, Higashino K, Numata Y, Nishijima K, Zhao S, Tamaki N, Ogawa M, Kuge Y
The 63rd Society of Nuclear Medicine Annual Meeting (SNMMI 2016)   11 Jun 2016   Society of Nuclear Medicine Annual Meeting
FMISO PETイメージングによるeribulinの腫瘍内低酸素状態解除作用の実証―小動物用PETと乳癌モデルを用いた検討―
趙 松吉、于 聞文、右近 直之、西嶋 剣一、志水 陽一、東川 桂、安井 博宣、山下 啓子、玉木 長良、久下 裕司
第12回小動物インビボイメージング研究会   30 Jul 2016   小動物インビボイメージング研究会
FMISO PETイメージングによるeribulinの腫瘍内低酸素状態解除作用の評価
趙 松吉、于 聞文、右近 直之、西嶋 剣一、志水 陽一、東川 桂、安井 博宣、山下 啓子、玉木 長良2、久下 裕司
第31回福島県核医学研究会   10 Sep 2016   
Current Status and Future Prospects of Molecular Imaging and Targeted Radionuclide Therapy in Fukushima Medical University [Invited]
Zhao S, Oriuchi N, Aoki M, Tominaga H, Kubo H, Oda T, Kato J, Taniguchi M, Hiasa T and Takenoshit S
Asian Forum for Accelerators and Detectors (AFAD 2017)   16 Jan 2017   Asian Forum for Accelerators and Detectors
Preclinical evaluation of thymidine phosphorylase imaging probe, [123I]IIMU, A road to First-in-human clinical study
Nishijima K, Zhao S, Matsumoto H, Akizawa H, Ohkura K, Shiga T, Hirata K, Watanabe S, Okamoto S, Tamaki N, Kuge Y
Ninth Japan-China Joint Seminar on Radiopharmaceutical Chemistry (JCSRC 2015)   8 Nov 2015   
Preclinical Translational Researches of Novel PET and SPECT Tracers: 18F-FDiFA and 123I-IIMU for Hypoxia and Thymidine Phosphorylase Imaging [Invited]
Songji Zhao
The Asia Oceania Federation of Nuclear Medicine and Biology (AOFNMB) 2015   31 Oct 2015   
Study of accumulation mechanism of hypoxia imaging probe “FMISO” in tumors by imaging mass spectrometry: A possible involvement of low-molecular metabolites
Masaki Y, Shimizu Y, Yoshioka Y, Tanaka Y, Higashino K, Sakamoto S, Numata Y, Yamaguchi Y, Nishijima K, Zhao S, Tamaki N, Kuge Y
The 2015 World Molecular Imaging Congress   2 Sep 2015   
Dynamic PET evaluation of the increased FLT accumulation after sorafenib treatment in mice bearing a human renal cell carcinoma xenograft
Ukon N, Zhao S, Yu W, Shimizu Y, Nishijima K, Kubo N, Tamaki N,Kuge Y.
The 2015 World Molecular Imaging Congress   2 Sep 2015   
Expression level of fatty acid-binding protein 5 increased in pro-inflammatory macrophage with atherosclerotic lesion formation; evaluation as a potential biomarker for atherosclerosis imaging
Shimizu Y, Hanzawa H, Zhao Y, Zhao S, Sakamoto T, Tamaki N, Kuge Y
The European Society of Cardiology (ESC) Congress 2015   29 Aug 2015   
Sphigomyelin synthase 2 deficiency enhances glucose clearance and tissue uptake in mice
Sugimoto M, Shimizu Y, Zhao S, Ukon N, Nishijima K, Wakabayashi M, Yoshioka T, Higashino K, Numata Y, Tamaki N, Igarashi Y, Kuge Y
The 14th International Conference on Bioactive Lipids in Cancer, Inflammation, and Related Diseases   12 Jul 2015   
Thymidine phosphorylase (TP) expression in normal mice: comparison with biodistribution of a novel TP imaging probe
Zhao S, Li H, Nishijima K, Shimizu Y, Tamaki N, Kuge Y
The 62nd Society of Nuclear Medicine Annual Meeting   6 Jun 2015   
Accumulation mechanism of non-targeted immunoglobulin G in atherosclerotic legions
Shimizu Y, Hanzawa H, Zhao Y, Fukura S, Nishijima K, Sakamoto T, Zhao S, Tamaki N, Kuge Y
The 62nd Society of Nuclear Medicine Annual Meeting   6 Jun 2015   
Hypoxia imaging with 18F-fluoromisonidazole for differentiating tumors from granulomas: a comparison with 18F-/14C-FDG in experimental rat models.
2014   
Effects of feeding conditions on the myocardial and hepatic accumulation of radioiodine-labeled BMIPP in mice.
2014   
Changes in tumor oxygen states after sorafenib therapy evaluated by using 18F-fluoromisonidazole hypoxia imaging in a renal cell cancer xenograft.
2014   
Evaluation of dynamic changes in tumor hypoxia and proliferation after radiotherapy in human head and neck cancer xenograft using dual tracers of FMISO and FLT.
2014   
Mechanisms of anti-tumor effects underlying sorafenib treatment: evaluation of tumor oxygen states using 18F-FMISO in a human lung cancer xenograft.
2014   
Increased metabolite levels of glycolysis and pentose phosphate pathway in rabbit atherosclerotic arteries and hypoxic macrophage.
2014   
Irbesartan reduces atherosclerosis in Watanabe Heritable Hyperlipidemic (WHHL) rabbits: Non-invasive imaging of inflammation with 18F-FDG PET
2013   
Effects of feeding conditions on the hepatic pharmacokinetics of radioiodine-labeled BMIPP in mice: Comparison with palmitic acid.
2013   
Dose-dependent elevation of 18F-FDG concentration in the blood after ARB administration: Experiment in mice given telmisartan.
2013   
FMISO PET reflects antiangiogenic tumor response after sorafenib treatment in human renal cell carcinoma xenograft.
2013   
Sequential evaluation of intratumoral proliferative activity after radiotherapy by FLT in human head and neck cancer xenograft.
2013   
Radioiodinated BMIPP as a potential probe for hepatic fatty acid metabolism: evaluation in mice at different feeding status.
2013   
Monitoring tumor proliferative activity after radiotherapy by FLT in head and neck cancer xenograft comparison with Ki67.
2013   
Increased intratumoral FLT uptake after multi-kinase inhibitor sorafenib treatment in human renal cell carcinoma xenograft.
2012   
Monitoring intratumoral proliferative and hypoxic responses to radiotherapy by FLT and FMISO in human head and neck cancer xenograft.
2012   
FLT can early reflect response of tumor proliferation to multikinase inhibitor (sorafenib) treatment in a human renal cell carcinoma xenograft: comparison with Ki-67.
2012   
骨髄間質細胞移植は脳梗塞周囲の神経受容体機能を改善させる―123I‐iomazenil SPECTによる検討
2012   
腎細胞癌移植マウスにおけるマルチキナーゼ阻害剤Sorafenib治療後のFLTによる治療反応評価
2012   
がんの診断・治療効果評価におけるPETの応用~基礎研究を中心に~
2012   
腫瘍・肉芽腫における18F‐FMISO集積の特徴:18F‐FDG及び組織学的比較
2012   
放射線照射により生成される一酸化窒素は固形腫瘍の再酸素化に必須である.
2012   
動脈血栓能を反映する18F‐フルオロデオキシグルコースの血管集積
2012   
Prediction of early antiproliferative response to anti-VEGF monoclonal antibody molecular-targeting therapy (bevacizumab) in human tumor xenograft using FLT
2009   
固形腫瘍内における放射線誘導性再酸素化の動態の評価
2012   
18F-FLT can detect early antiproliferative response to anti-EGFR molecular targeting therapy (cetuximab) in human lung cancer xenograft.
2009   
FMISO PET reflects antiangiogenic tumor response to multi-kinase inhibitor (sorafenib) in human renal cell carcinoma xenograft.
2012   
18F-FLT but not 18F-FDG can early and dose-dependently detect antiproliferative responses of human tumor xenograft to epidermal growth factor receptor targeting with a tyrosine kinase inhibitor, gefitinib
2007   
Usefulness of [C-11]methionine in differentiating tumor from granuloma: Comparison with [F-18]FDG
2006   
Suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE-/- mice: Molecular imaging with 14C-FDG and 99mTc-annexin A5.
2011   
Omeprazole modifies physiologic FDG uptake in the GUT.
2004   
Dynamic MET PET analysis has an additional value for differentiating tumors from granulomas: An experimental study using small animal PET
2009   
18F-Fluorothymidine (18F-FLT) as early predictor of tumor response for anti-epidermal growth factor receptor antibody in human lung cancer xenograft.
2011   
Biologic correlates of intratumoral heterogeneity in FDG distribution with regional expressions of glucose transporters and hexokinase-II in experimental tumors.
2003   
Monitoring Early Response to Molecular-Targeting Therapy (Iressa) in Human tumor xenograft using 18F-FLT.
2006   
Dominant negative HIF-1a reduces FDG uptake in pancreatic cancer cells
2002   
FMISO PET can early evaluate antiangiogenic response to anti-EGFR molecular-targeting therapy (cetuximab) in human lung cancer xenograft.
2011   
骨髄間質細胞移植は脳梗塞周囲の受容体機能を改善させる―123I‐iomazenil SPECTによる検討
齋藤久泰, 黒田敏, 宮本倫行, 山内朋裕, 新保大輔, 七戸秀夫, 趙松吉, 孫田惠一, 久保直樹, 久下裕司, 玉木長良, 寶金清博
再生医療   2012   
Effects of insulin and glucose loading on FDG uptake and GLUT expression in experimental inflammatory lesions and tumors
2002   
Effects of insulin and glucose loading on FDG uptake in experimental inflammatory lesions and malignant tumors
2001   
Dynamics of 18F-FDG Uptake in Experimental Granuloma and Tumor: Basic Studies in Rat Models Using Small Animal PET/CT System
2008   
18F-Fluorothymidine PET/CT as early predictor of tumor response for anti-epidermal growth factor receptor antibody in human lung cancer xenograft.
2011   
Application of semiconductor gamma-camera for whole-body dynamic SPECT in small animal imaging.
2006   
A novel radiolabeled probe for molecular imaging of thymidine phosphorylase: Suppressed accumulation into tumor cells by target gene knockdown.
2010   
Biologic Features of Intratumoral 18F-FMISO Distribution in a Rat Model of Glioma.
2012   
Early Evaluation of Antiangiogenic Response to Anti-EGFR Molecular Targeted therapy (cetuximab) by Using FMISO PET in Human Lung Cancer Xenograft.
2011   
Evaluation of intratumoral 18F-FDG distribution using small animal PET: Comparison with autoradiography.
2010   
11C-Methionine but not 18F-FDG and 18F-FLT can differentiate tumor from granuloma in experimental rat models.
2006   
PREDICTION OF EARLY ANTIPROLIFERATIVE RESPONSE TO ANTI-EGFR MOLECULA-TARGETING THERAPY (CETUXIMAB) IN HUMAN TUMOR XENOGRAFT USING 18F-FLT PET.
2010   
A radiolabeled uracil derivative as a novel SPECT tracer for thymidine phosphorylase (TP): cell specific uptake responses to TP expression.
2010   
Evaluation of early response to epidermal growth factor receptor targeting therapy with the tyrosine kinase inhibitor, gefitinib (Iressa) in human xenograft using 18F-FLT.
2006   
Biological characteristics of intratumoral 18F-FMISO distribution in a rodent model of glioma.
2010   
Utility of 99mTc-annexin A5 for Evaluating the Therapeutic Effect of ARB on Atherosclerosis: an Experimental Study with Telmisartan Treated apoE-/- Mice.
2011   
Dynamics of 18F-FDG uptake in experimental granulomas induced with activated macrophages: Comparison with malignant tumors
2008   
Hypoxia imaging with 18F-fluoromisonidazole (FMISO) for differentiating tumors from granulomas: a comparison with FDG in experimental rat models using small animal PET.
2010   
Modification of FDG uptake by steroid pretreatment: a potential means for differentiating tumor from granuloma by PET
2005   
FLT PET can early predict antiproliferative response to anti-EGFR molecular-targeting therapy (cetuximab) in human lung cancer xenograft.
2010   
Biologic aspects of intratumoral [18F]FMISO distribution in a rodent model of glioma.
2010   
Performance evaluation of a semiconductor spect system for small animal imaging.
2005   
Careful assessment of FDG uptake due to elevated FDG concentration in the blood and organs by high dose ARB administration: Experiment in mice given telmisartan.
2010   
The therapeutic effect of telmisartan on atherosclerosis in apoE-/- mice: an evaluation with 99mTc-annexin A5.
2011   
Dynamic 11C-MET pet has an additional value for differentiating tumors from granulomas: an experimental study using small animal pet in comparison with 18F-FDG.
2009   
Is MET valuable in differentiating cancer from granuloma?
2004   
Evaluation of FMISO uptake in rat tumor tissue:comparison with FDG uptake.
2009   
Usefulness of 11C-methionine in evaluating cellular proliferation and differential diagnosis of tumor and granuloma
2007   
18F-Fluorothymidine (FLT) as tumor response predictor for anti-epidermal growth factor receptor (EGFR) antibody in human lung cancer xenograft.
2009   
The effect of steroid on FDG uptake in experimental tumor, granulomatous and inflammatory lesions
2004